(Q24800282)

English

Progesterone receptors--animal models and cell signalling in breast cancer. Implications for breast cancer of inclusion of progestins in hormone replacement therapies

scientific article

In more languages

Statements

scholarly article

0 references

1 reference

21 April 2021

Progesterone receptors--animal models and cell signalling in breast cancer. Implications for breast cancer of inclusion of progestins in hormone replacement therapies (English)

0 references

breast neoplasm

1 reference

21 April 2021

1 reference

17 November 2019

progesterone receptor

1 reference

2 August 2020

hormone replacement therapy

1 reference

21 April 2021

1 reference

Catherine Schairer

1

object named as

Catherine Schairer

0 references

language of work or name

0 references

publication date

7 October 2002

8 references

13 March 2019

3 April 2019

17 June 2019

25 June 2019

17 November 2019

21 December 2019

2 August 2020

21 April 2021

Breast Cancer Research

8 references

13 March 2019

3 April 2019

17 June 2019

25 June 2019

17 November 2019

21 December 2019

2 August 2020

21 April 2021

4

0 references

244-8

0 references

6

0 references

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

7 April 2017

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

7 April 2017

Postmenopausal estrogen and progestin use in relation to breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 September 2017

Hormone replacement therapy and the risk of death from breast cancer: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 September 2017

Combined oral hormone replacement therapy formulations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 September 2017

Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 September 2017

Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 September 2017

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 September 2017

Epithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 September 2017

Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 September 2017

Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

30 May 2018

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

30 May 2018

Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

30 May 2018

Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

30 May 2018

Prescribing of hormone therapy in menopause and postmenopause.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

30 May 2018

Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

30 May 2018

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

https://api.crossref.org/works/10.1186%2FBCR540

21 January 2018

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

1 reference

https://api.crossref.org/works/10.1186%2FBCR540

21 January 2018

Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?

1 reference

https://api.crossref.org/works/10.1186%2FBCR540

21 January 2018

Mammographic density changes during different postmenopausal hormone replacement therapies

1 reference

https://api.crossref.org/works/10.1186%2FBCR540

21 January 2018

Mammographic density increase in women receiving different hormone replacement regimens

1 reference

https://api.crossref.org/works/10.1186%2FBCR540

21 January 2018

Megatrials of hormonal replacement therapy.

1 reference

https://api.crossref.org/works/10.1186%2FBCR540

21 January 2018

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1186%2FBCR540

21 January 2018

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 November 2018

Effects of sex steroids on proliferation in normal mammary tissue.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=137941

28 November 2018

Estradiol and progesterone regulate the proliferation of human breast epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/12473171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mammographic breast density during hormone replacement therapy: differences according to treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/12473171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/12473171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle-aged women

1 reference

https://pubmed.ncbi.nlm.nih.gov/12473171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of cancer among women using long versus monthly cycle hormonal replacement therapy, Finland 1994-1997

1 reference

https://pubmed.ncbi.nlm.nih.gov/12473171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hormone replacement therapy in relation to breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/12473171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen and estrogen-progestin replacement therapy and risk of postmenopausal breast cancer in Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/12473171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12473171

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Springer Nature article ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24800282&oldid=1833364489"